RAVINDRA REDDY: Open Payments
NPI 1487679478 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 36 payments from 8 companies in 2025. Trend: 2023 $1,254 · 2024 $1,295 · 2025 $585
Food & beverage: $542Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 8 | $160 |
| ABBVIE INC. | 14 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Almatica Pharma LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, LOREEV XR, Auvelity, TRINTELLIX.
Industry payments across LA — which companies pay providers there.
